Anthem Biosciences Limited — Board Meeting, 13-08-2025: Outcome of Board Meeting

Anthem Biosciences' Board has approved its latest financial results, showcasing impressive growth for the quarter ended June 30, 2025. Consolidated revenue from operations surged to ₹540.21 Cr, while profit for the period climbed to ₹135.79 Cr. This solid performance indicates a strong operational quarter. The company also announced the redesignation of Mr. Ravi Kalla as Chief Information Officer, a strategic move acknowledging his extensive experience and leadership in advancing Anthem's technology initiatives.